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Renal phosphate reabsorption in the rat: Effect of inhibitors. The
maximum rate of inorganic phosphorus (F1) reabsorption (Tmp)
was measured during phosphate infusion in chronically
parathyroidectomized rats. In either initially hydropenic rats or
others which underwent moderate preliminary saline loading, Tm1
tended to rise during early phosphate infusion and then decline, so
that steady-state Tm values were similar to the P1 reabsorption
rates at the animals' own evelated endogenous plasma P1 con-
centrations. These results indicate that the "self-depression" of
Tmp during phosphate infusion is not dependent upon the
progressive stimulation of endogenous parathyroid hormone secre-
tion. Parathyroid hormone and dibutyryl cyclic adenosine
monophosphate (AMP) decreased Tm substantially, whereas
acetazolamide inhibited F, reabsorption at lower filtered P, loads
but did not diminish Tm,.1.
Reabsorption rénale du phosphate chez le rat: Effet des inhibiteurs.
Le debit maximal de reabsorption de phosphate inorganique
(Tm,.) aété mesuró au cours de Ia perfusion de phosphate chez des
rats parathyroi'dectomisés chroniques. Chez les animaux initiale-
ment hydropeniques aussi bien que chez ceux qui ont subi préa-
lablement une expansion saline modérée, Tm,., tend a augmenter
au debut de La perfusion de phosphate pour diminuer ensuite, de
telle sorte qu'ã l'état stationnaire de Tm,. Ia reabsorption de
phosphate est semblable a celle observée chez l'animal a l'état
basal, au cours de l'augmentation spontanée de Ia concentration
plasmatique du phosphate inorganique. Ces rCsultats indiquent
que Ia "depression" de Tm,. au cours de Ia perfusion de phosphate
ne depend pas de Ia stimulation progressive de Ia secretion d'hor-
mone parathyroldienne. L'hormone parathyroldienne et le
dibutyryl AMP cyclique diminuent Ic Tm1., de facon importante,
alors que l'acétazolamide inhibe Ia reabsorption de phosphate
pour des debits filtrés inférieurs mais ne diminue pas Tm,..
The renal handling of inorganic phosphate (P,)
usually is considered to include almost complete
filtration at the glomerulus and subsequent partial
reabsorption [1]. Ever since the work of Pitts and
Alexander [2], the reabsorptive process has been con-
sidered to be limited by a maximum transport
capacity (Tmp), demonstrable by elevating the
filtered load of P1 through phosphate infusion. Ex-
periments in the intact rat have demonstrated an ap-
parent Tm which declined progressively during
phosphate infusion [3]. That observation, similar to
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others in the dog [4, 5] and cat [6], could have
resulted from the progressive stimulation of para-
thyroid hormone (PTH) secretion by hypocalcemia
during phosphate loading, and the progressive
inhibition of Tmp, thereby [7]. In addition, expan-
sion of the extracellular fluid volume by saline
infusion can decrease Imp, in the dog [8], and
conceivably a similar inhibition of P, reabsorption
could occur during sodium phosphate infusion.
In the present experiments we have measured Tmp
in the chronically parathyroidectomized rat. The con-
tribution of progressive volume expansion, during
sodium phosphate infusion, to a decline in Imp has
been evaluated by comparing P, reabsorption in in-
itially hydropenic rats with values in other animals
which underwent moderate NaCI loading prior to
phosphate infusion. We also have measured Tm in
animals treated with the phosphaturic agents PTH,
dibutyryl adenosine-3',S'-cyclic monophosphate
(dbC-AMP) and acetazolamide.
Methods
Clearance studies were performed on para-
thyroidectomized male Sprague-Dawley rats weigh-
ing 235 to 425 g and maintained on standard chow
containing 1.4% calcium and 1% phosphorus.
Parathyroidectomy was performed by electrocautery
three to eight days prior to the clearance study. The
criterion for satisfactory parathyroidectomy was a
serum calcium concentration less than 7 mg/l00 ml
when sampled two or more days after surgery.
Food was withheld 16 hr prior to each clearance
study. Anesthesia was obtained with Inactin
(Promonta, Hamburg), 80 to 100 mg/kg i.p., and a
tracheostomy was performed. Cannulae of PE 50
tubing were secured in the left carotid artery, both ex-
ternal jugular veins and in the bladder. The mean
arterial pressure was monitored by a transducer con-
nected in the arterial line. Animals received 10 mI/kg
of 150 mrvi NaC1 iv. to replace surgical losses and
were placed on an electrically heated platform and
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maintained at a body temperature of 36 to 38°C
while monitored rectally by a thermistor probe. An
8% inulin solution was administered as a priming
dose, 1 mi/kg i.v., and contined as a sustaining infu-
sion at 4 mi/kg/hr. After a one-hour equilibration in-
terval, specimens for nine consecutive 20-mm
clearance periods were collected. Sufficient arterial
blood was obtained at the midpoint of each clearance
period to allow the separation of 80 l of plasma.
Urine was collected under mineral oil and the volume
determined by differential weighing. After two con-
trol clearance periods were completed, 150 mM
sodium phosphate solution (Na2HPO4 and NaH2PO4
at approximately a 4: 1 ratio, adjusted to pH 7.4) was
infused at 15 mI/kg/hr and continued for the remain-
ing seven 20-mm clearance periods. Tetany was
prevented by the infusion of calcium at a rate of 6.6
mg/kg/hr through the addition of 0.17% calcium (as
calcium chloride) to the inulin solution. Calcium was
administered throughout the equilibration interval
and clearance periods in all the studies except those
employing PTH infusion (see following).
In eight rats, control clearance periods commenced
during hydropenia. Eight other rats received an ad-
ditional infusion of 150 mM NaCI at 30 mI/kg/hr
throughout the one-hour equilibration interval and
during the two control clearance periods. The NaCl
infusion was discontinued at the beginning of period
3 when the phosphate infusion commenced.
The effects of the phosphaturic agents PTH, dbC-
AMP and acetazolamide were investigated in other
parathyroidectomized rats which were prepared dur-
ing the equilibration interval and control clearance
periods exactly as described for the NaC1-loaded rats.
The PTH, dbC-AMP or acetazolamide was ad-
ministered in the inulin solution throughout the
equilibration interval and during all nine clearance
periods. A purified PTH preparation (Wilson
Laboratories, Chicago, IL) was infused in six studies
at 30 pg/kg/hr, after initially dissolving the PTH in a
solution containing 1% albumin. Dibutyryl cyclic
AMP (Sigma, St. Louis, MO) was infused during
eight experiments at a rate of 10 mg/kg/hr. In seven
other experiments, acetazolamide was given as an in-
itial priming dose of 20 mg/kg and an infusion at 20
mg/kg/hr. During the acetazolamide experiments,
the animals received additional 150 mM NaCl at 30
mi/kg/hr in order to replace urinary losses.
Ultrafilterable plasma calcium concentration and
P1 were determined in other chronically para-
thyroidectomized rats, treated similarly to the
NaCI-loaded group, both with and without sodium
phosphate infusion. Plasma was equilibrated with 5%
CO2 under mineral oil and centrifuged through collo-
dion bags (Schleicher and Schuell, Keene, NH) at
37°C. In 8 rats, the percentage of ultrafilterable
calcium averaged 52.0 4.4% (mean SEM) after
phosphate loading, as compared to 54.8 1.7% in 11
animals without phosphate loading. Ultrafilterable Pi
averaged 103.4 1.5% in the phosphate-loaded rats
as compared to 107.6 1.7% without phosphate
loading.
Plasma and urine were diluted appropriately in a
1% lanthanum—5% tricholoracetic acid solution.
Inulin [9] and P1 [101 were measured by semi-
automated methods, calcium was measured by
atomic absorption spectrophotometry and sodium
and potassium were measured by flame photometry.
Values of inulin clearance (glomerular filtration
rate, GFR), filtered load and solute excretion are ex-
pressed per 100 g of body wt in the text, tables and
figures. For each clearance study, the values for
periods 1 and 2 were averaged ("control" values),
values for periods 3 and 4 were averaged ("early
phosphate infusion", from 0 to 40 mm) and the
values for periods 7 through 9 were averaged ("late
phosphate infusion", from 80 to 140 mm). Statistical
comparisons were made utilizing the paired or un-
paired Student's t test, as appropriate [11].
Results
P1 reabsorption in hydropenic and NaCI-loaded rats.
During the control phase and early phosphate infu-
sion, plasma P1 values were significantly greater in the
hydropenic animals (P < 0.005 and <0.05, respec-
tively), and the GFR increased significantly in that
group (P < 0.005; Table 1, Fig. 1). P1 reabsorption in-
itially increased in both groups (P < 0.005). During
late phosphate infusion, filtered P1 in several
hydropenic rats declined (Fig. 1) because of a return
of the GFR to control levels (Table 1). Con-
comitantly, P1 reabsorption also declined (P < 0.005)
to control levels, despite the fact that filtered P1
stabilized at approximately twice the initial values
(Fig. I). In contrast, filtered P1 increased progres-
sively in the group which had received preliminary
NaC1 loading (Fig. 1, Table 1). P1 reabsorption also
increased during early phosphate infusion in the
NaC1 group, but subsequently declined (P < 0.001)
to values similar to control (Fig. 1). Again, this oc-
curred despite the stabilization of filtered P1 at ap-
proximately twice the control values. Thus, P1 reab-
sorption at the animals' own endogenously
hyperphosphatemic plasma P1 was very similar to the
steady-state Tmp during late phosphate infusion in
both groups.
P1 reabsorption and GFR were correlated in both
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Table I. Inorganic phosphatereabsorption in parathyroidectomized ratsa
Plasma P,
mg/lW ml
Filtered P1
i.sg/min/lOOg
P1 reabso
g/min/lWg
rption
ig/ml GFR
FE1 X 100
%
GFR
ml/min/lWg
Hydropenia (N = 8)
Control 11.4
(±0.4)
97.3
(±4.4)
87.0
(±4.1)
100
(+4)
11.9
(+1.9)
0.87
(±0.06)
Earlyphosphateinfusion
Late phosphate infusion
18.6°
(+0.9)
25,1b
(±2.9)
210
(±11)
191
(±8)
155b
(±14.5)
78.8
(±3.3)
131b
(±7)
108
(+18)
277b
(±3.5)
58.5
(+2.2)
(±0.09)
0.84
(±0,10)
NaCI (N = 8)
Control 9.6
(±0.3)
93.2
(+5.8)
86.6
(±5.9)
89.0
(+2.7)
7.32
(±1.29)
0.98
(±0.07)
Earlyphosphateinfusion
Latephosphateinfusion
14.5°
(±0.5)
21.1"
(+1.7)
150°
(±9)
178b
(±9)
121°
(±7.4)
91.8
(±6.9)
ll8l
(±5)
108°
(+9)
j7,7C
(+2.2)
48.3'
(+3.5)
1.05
(±0.09)
0.89
(+0.09)
Parathyroid hormone +
NaCl (N = 6)
Control 7.5
(±0.6)
85.0
(±5.3)
62.0
(+5.4)
55.0
(±5.6)
27.5
(+2.4)
1.15
(±0.07)
Early phosphate infusion
Late phosphate infusion
.6"
(±0.6)
16.6"
(±0.9)
125b
(±8)
179°
(+9)
69.5
(±6.2)
58.2
(±7.8)
64.4
(±3.4)
54.2
(+7.4)
42,9b
(+2.2)
67.9"
(±3.1)
1.08
(±0.07)
1.09
(±0.08)
Dibutyryl cyclic AMP + NaCI
(N=8)
Control 5.88
(±0.28)
62.4
(±4.8)
44.2
(±4.4)
41.2
(±2.8)
29.8
(+1.7)
1.07
(±0.06)
Early phosphate infusion
Late phosphate infusion
9.27b
(±0.60)
14,9°
(±1.3)
85.8"
(±7.1)
121b
(±7)
499
(±5.8)
44.7
(+4.9)
546b
(+6.7)
57.6
(+9.6)
409C
(±3.5)
63.0"
(+3.6)
Q94C
(±0.06)
0.86'
(±0.08)
Acetazolamide + NaCl (N = 7)
Control 10.1
(+0.3)
79.4
(±3.2)
61.9
(+2.1)
78.7
(±1.8)
21.8
(+2.7)
0.79
(+0.03)
Early phosphate infusion 16.1°
(±0.3)
131°
(±5)
84.2"
(±3.3)
l4"
(±3.1)
34,9°
(+2.6)
0.82
(±0.02)
Latephosphateinfusion 22.6°
(±0.7)
187°
(±8)
89.3"
(±5.8)
108b
(±6.2)
52.8
(±1.2)
0.83
(±0.03)
a All values are means SEM. "Control" = mean of two 20-mm clearance periods preceding phosphate infusion; "early phosphate
infusion" = mean of first two 20-mm clearance periods during 150 msi sodium phosphate infusion at 15 ml/kg/hr; "late phosphate
infusion" mean of last three 20-mm clearance periods, 80 to 140 mm following start of phosphate infusion. "NaCI" refers to infusion
of 150 mi NaCI at 30 mi/kg/hr during equilibration interval and control clearance periods.
b,c,d Superscripts indicate paired comparisons with control values as follows: bp < 0.005, C < 0.05, "P < 0.01. Otherwise, P> 0.1.
the hydropenic (r = 0.73; P < 0.005) and NaC1-
treated groups (r = 0.72; P < 0.005). Control arterial
pressures averaged 115 4 mm Hg in the hydropenic
and 115 6 mm Hg in the NaC1-treated groups.
Arterial pressure did not change significantly during
early phosphate infusion in either group, but
declined during late phosphate infusion to 81 5 mm
Hg in the hydropenic and 90 6 mm Hg in the NaC1
group (P < 0.001 for both).
Control absolute and fractional sodium excretions
were significantly less in the hydropenic group (P <
0.005; Table 2). Sodium excretion increased subse-
quently in both groups, although to a greater extent
in the hydropenic animals which had the lower initial
values. Plasma calcium concentrations were similar
in both groups. Calcium excretion showed a tendency
to increase only in the hydropenic rats (Table 2).
Phosphaturic agents. The effects of PTH, dbC-
AMP and acetazolamide on P1 reabsorption after
preliminary NaC1 loading were examined in similar
studies, except that either PTH, dbC-AMP or
acetazolamide was begun at the onset of the
equilibration interval (Fig. 2, Table 1). In the PTH
and dbC-AMP groups, P1 reabsorption did not in-
crease appreciably despite a doubling of filtered P1. In
the dbC-AMP experiments, filtered P1 usually
remained less than in the PTH group and the group
which had received only NaCI (Fig. 2). However,
filtered P1 in the dbC-AMP animals during late
phosphate infusion was significantly greater than
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Fig. 1. Filtered and reabsorbed phosphorus (P1) during control
periods and early or late phosphate loading in individual hydropenic
or NaCI-loaded rats. Each point indicates the mean of two or three
clearance periods (see Methods), with lines connecting points from
the same animal. P1 reabsorption increased in all animals during
early phosphate loading, but subsequently declined to the control
range during late phosphate loading. Although filtered P1 tended to
decrease between early and late phosphate loading in the
hydropenic group (because of a change in GFR), filtered P, in-
creased steadily throughout phosphate infusion in the NaCI-
loaded rats.
control filtered P1 in the rats receiving only NaC1 (P
< 0.05). Yet, P1 reabsorption in the dbC-AMP rats
was only 45 5 tg/min/l00 g, as opposed to 87 6
itg/min/l00 g in the NaCI rats without dbC-AMP (P
<0.001). In the rats receiving PTH, filtered P1 during
early and late phosphate infusion increased in a
fashion similar to the rats receiving NaC1 alone, but
P1 reabsorption did not increase (Fig. 2, Table 1). The
failure of P1 reabsorption to increase with the filtered
P1, from the depressed control values, indicates that
Tmp was diminished in both groups.
In contrast, P1 reabsorption increased steadily dur-
ing phosphate infusion in the acetazolamide group
(Fig. 2, Table I). Although control P1 reabsorption in
that group was significantly less than in the rats
receiving NaC1 alone (P < 0.005), P1 reabsorption
during late phosphate infusion was very similar in
both groups. Acetazolamide inhibited P1 reabsorp-
tion until very high P1 filtered loads were achieved.
Thus, unlike PTH and dbC-AMP, acetazolamide did
not decrease Tmp, but instead appeared to increase
the "splay" of the phosphate reabsorption curve.
Absolute and fractional sodium excretion rates in
the PTH and dbC-AMP groups were similar to those
of the group receiving NaC1 alone, while a
pronounced natriuresis occurred throughout in the
acetazolamide rats (Table 2). Potassium excretion
ranged from 5.6 0.6 to 8.1 0.4 cEq/min/l00 gin
the hydropenic, NaC1, PTH and dbC-AMP groups,
in contrast to a maximum of 13.7 0.8 tEq/min/100
g in the acetazolamide group during late phosphate
infusion. Plasma calcium concentration remained
between 5 and 6.5 mg/lOO ml in all except the PTH-
treated rats, the group which did not receive calcium
i.v. Only very small increases in absolute calcium ex-
cretion occurred (Table 2), indicating that any in-
crease in phosphate excretion due to complexing with
calcium probably was very minor.
Discussion
In these parathyroidectomized rats, Tm1 increased
initially during phosphate infusion but subsequently
declined, irrespective of the presence or absence of
prior NaCI loading (Fig. 1). This pattern of "self-
depression" is similar to that observed by Frick dur-
ing phosphate infusion studies in nonparathyroidec-
tomized rats [3]. In Frick's experiments, a progressive
decline in Tm1 could have been attributed to increas-
ing rates of endogenous PTH secretion [7], unlike the
present findings in parathyroidectomized animals.
Values of Tmp1 also have been considered to
vary with the GFR in the dog [12], cat [6] and man
[13, 14]; and Tm1 was correlated significantly with
the GFR in our experiments. Despite this correlation,
factoring the P1 reabsorption values by GFR did not
change the pattern of response to phosphate infusion
markedly (Table 1). Thus, although small changes in
GFR might have affected Tmp in our experiments,
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Table 2. Sodium and calcium handling during inorganic phosphate infusion in parathyroidectomized rats
a FEca, fraction of ultrafilterable calcium excreted.
b,c.d Superscripts indicate paired comparisons with control values as follows:
such a relationship would be difficult to evaluate
because the GFR was not varied systematically.
Progressive extracellular fluid volume expansion
by the sodium phosphate infusion might have caused
a decline in Imp1 with time [81. During control
periods in the present studies, mean FEE, was slightly
greater in the hydropenic rats than in the NaC1-
loaded group, but the substantially greater control
plasma P1 in the former group makes the interpreta-
tion of those control values difficult. During late
phosphate loading, the pattern of P1 reabsorption
differed little between the two groups. Studies by
Frick in the acutely parathyroidectomized rat in-
dicated that volume expansion with saline does not
elicit a phosphaturic response in that preparation
[15]. In contrast, saline loading appears to depress
Im in the thyroparathyroidectomized dog if the
plasma phosphorus concentration is elevated suffi-
ciently [16]. Our results do not bear directly on the
question of an effect of volume expansion on Imp in
p < 0.005, cp < 0.05, dp < 0.01, Otherwise, P> 0.1.
the chronically parathyroidectomized rat because
NaCI loading was not continued during phosphate
infusion. They do suggest, however, that progressive
volume expansion may not be entirely responsible
for the "self-depression" of Tm1 with continued
phosphate infusion.
Although it has been suggested that progressive
potassium depletion may depress Tmp1 [4], potassium
excretion and Tm were not inversely correlated in
our experiments. Magnesium deficiency has been
reported to depress Tm1 [17], whereas vitamin D
metabolites may enhance P1 reabsorption [18, 19].
The rats utilized in our studies were obtained from a
common source and maintained on the same stan-
dard chow, making differences in vitamin D or mag-
nesium metabolism unlikely. Calcium infusion has
been reported to stimulate P1 reabsorption in the
parathyroidectomized rat, but only after a substantial
increase in the plasma calcium concentration [19,20].
In our experiments, only sufficient calcium was in-
Plasma Ca
mg/100 ml
Ca excretion
g/min//OO g
FEE. X l00
%
Plasma Na
mEq/liter
Na excretion
tEq/min/1OO g
FENa X 100
%
Hydropenia (N = 8)
Control 5.8
(±0.4)
1.73
(±0.26)
0.69
(±0.11)
135
(±1)
5.6
(±0.9)
0.53
(±0.08)
Early phosphate infusion
Late phosphate infusion
5.8
(±0.3)
5.5
(±0.3)
5.00"
(±0.84)
4•17b
(±0.59)
153b
(±0.26)
183b
(+0.28)
138b
(±1)
l40c
(+1.6)
199b
(±3.0)
336"
(±3.2)
146"
(±0.25)
3.12'
(+0.19)
NaCI (N = 8)
Control 5.4
(+0.2)
1.89
(±0.44)
0.69
(±0.16)
135
(±1.5)
16.9
(±2.4)
1.31
(±0.19)
Earlyphosphateinfusion
Late phosphate infusion
5.6
(±0.2)
5.2
(+0.3)
2.68
(±0.51)
2.16
(+0.59)
0.93
(±0,20)
0.97
(+0.29)
137d
(±1)
138'
(±1.7)
20.4
(±2,9)
29.2'
(±3.3)
1.53
(±0.21)
2,60e
(±0.29)
Parathyroid hormone + NaCI (N = 6)
Control 3.9
(±0.4)
1.30
(±0.37)
0.60
(±0.20)
136
(±1)
23.6
(±3.8)
1.64
(±0.29)
Early phosphate infusion
Latephosphateinfusion
3.8
(+0.3)
3.2"
(±0.3)
207d
(±0.46)
261"
(±0.53)
0.95
(±0.21)
1.37"
(±0.22)
136
(±0.8)
137
(+1)
34,6d
(±5.9)
43,9b
(±4.7)
2,50c
(±0.45)
3.14"
(±0.37)
Dibutyryl cyclic AMP + NaCI (N = 8)
Control 6.2
(±0.2)
6.9
(+2.1)
2.11
(+0.69)
138
(+3)
27.6
(+5.7)
2.08
(+0.99)
Early phosphate infusion 6.5c
(±0.2)
12.9c
(±3.5)
3.71
(±1,00)
139
(±3)
27.8
(±6.5)
2.26
(±0.53)
Late phosphate infusion 6.5c
(±0.1)
8.2
(±2.3)
2.63
(±0.63)
138
(±2)
26.9
(±5.4)
2.29
(±0.36)
Acetazolamide + NaCI (N = 7)
Control 5.9
(±0.2)
10.0
(±2.4)
3.88
(±1.11)
132
(±2)
69.3
(+11.6)
7.06
(+1.07)
Early phosphate infusion
Late phosphate infusion
5.8
(±0.2)
5.5
(±0.1)
15.6
(+3.7)
8.8
(±1.8)
5.88
(+1.32)
3.48
(±0.67)
131
(±2)
132
(±1)
73.8
(±9.8)
67.8
(±6.3)
7.20
(±0.81)
6.47
(±0.47)
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another laboratory [24]. In our experiments, PTH
and dbC-AMP decreased Tm, during late phosphate
infusion while acetazolamide did not. Unfortunately,
the present studies cannot distinguish whether this
resulted because of a fundamentally different
mechanism of action of acetazolamide, as opposed to
the possibility that uncontrolled experimental
variables might have interfered with its phosphaturic
properties.
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